Novo Nordisk blueprints $192M HQ in Bagsvaerd

Novo Nordisk plans to spend €134 million, or $192 million, to build two new headquarters buildings in Bagsværd, Denmark. The company will break ground in October, planning to consolidate operations from the greater Copenhagen area there when it's finished at the end of 2013. Report | Novo Nordisk release

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.